Diagnostics & Research
The Diagnostics & Research industry has a total of 53 stocks, with a combined market cap of $599.15 billion, total revenue of $161.45 billion and a weighted average PE ratio of 50.81.
Market Cap
599.15B
Revenue
161.45B
Profits
11.79B
PE Ratio
50.81
Profit Margin
7.30%
Dividend Yield
0.25%
53 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 159.54B | -0.22% | 2,637,154 | 42.90B |
| 2 | DHR | Danaher Corporation | 141.27B | -0.83% | 1,915,430 | 23.82B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 38.21B | 0.67% | 1,208,425 | 3.93B |
| 4 | A | Agilent Technologies, Inc. | 30.90B | -0.24% | 1,385,524 | 6.53B |
| 5 | IQV | IQVIA Holdings Inc. | 26.85B | -0.79% | 2,024,214 | 15.41B |
| 6 | MTD | Mettler-Toledo International Inc. | 22.68B | -0.81% | 232,961 | 3.83B |
| 7 | NTRA | Natera, Inc. | 21.38B | 0.36% | 883,860 | 1.70B |
| 8 | WAT | Waters Corporation | 20.73B | -0.59% | 697,946 | 2.96B |
| 9 | LH | Labcorp Holdings Inc. | 20.62B | -0.51% | 677,658 | 13.18B |
| 10 | DGX | Quest Diagnostics Incorporated | 19.82B | -0.21% | 834,592 | 10.16B |
| 11 | ILMN | Illumina, Inc. | 12.38B | 0.42% | 1,123,581 | 4.37B |
| 12 | ICLR | ICON Public Limited Company | 11.36B | 0.04% | 1,383,114 | 8.19B |
| 13 | RVTY | Revvity, Inc. | 11.16B | -1.17% | 705,281 | 2.77B |
| 14 | EXAS | Exact Sciences Corporation | 10.06B | 3.43% | 4,057,989 | 2.83B |
| 15 | QGEN | Qiagen N.V. | 9.25B | -0.77% | 1,253,540 | 1.98B |
| 16 | MEDP | Medpace Holdings, Inc. | 8.64B | -1.51% | 297,226 | 2.16B |
| 17 | CRL | Charles River Laboratories International, Inc. | 5.87B | 0.89% | 970,443 | 4.05B |
| 18 | GH | Guardant Health, Inc. | 5.46B | -5.98% | 3,446,546 | 774.00M |
| 19 | RDNT | RadNet, Inc. | 3.98B | -0.51% | 415,418 | 1.83B |
| 20 | SHC | Sotera Health Company | 3.67B | 4.44% | 1,796,793 | 1.11B |
| 21 | VCYT | Veracyte, Inc. | 2.44B | 3.20% | 861,419 | 445.76M |
| 22 | TWST | Twist Bioscience Corporation | 2.15B | -8.31% | 2,073,141 | 347.68M |
| 23 | WGS | GeneDx Holdings Corp. | 1.89B | -1.59% | 1,475,788 | 330.14M |
| 24 | NEOG | Neogen Corporation | 1.22B | -1.48% | 4,961,096 | 906.00M |
| 25 | GRAL | GRAIL, Inc. | 1.21B | -4.33% | 820,766 | 125.60M |
| 26 | OPK | OPKO Health, Inc. | 1.07B | -2.17% | 3,593,519 | 689.41M |
| 27 | NEO | NeoGenomics, Inc. | 1.01B | 1.82% | 3,113,353 | 672.36M |
| 28 | CDNA | CareDx, Inc | 845.51M | 1.23% | 1,432,927 | 346.42M |
| 29 | MYGN | Myriad Genetics, Inc. | 707.88M | 1.59% | 1,542,777 | 837.60M |
| 30 | FLGT | Fulgent Genetics, Inc. | 595.63M | -4.75% | 658,856 | 292.45M |
| 31 | CSTL | Castle Biosciences, Inc. | 540.27M | -3.20% | 535,298 | 332.07M |
| 32 | PSNL | Personalis, Inc. | 375.56M | 2.28% | 763,365 | 84.61M |
| 33 | STIM | Neuronetics, Inc. | 296.17M | -1.75% | 698,258 | 74.89M |
| 34 | ATLN | Atlantic International Corp. | 187.25M | -12.02% | 48,956 | 442.61M |
| 35 | ACRS | Aclaris Therapeutics, Inc. | 140.77M | -9.72% | 383,067 | 18.72M |
| 36 | XGN | Exagen Inc. | 110.34M | 2.41% | 275,188 | 55.64M |
| 37 | MDXH | MDxHealth SA | 86.62M | 1.74% | 19,728 | 90.05M |
| 38 | OCX | OncoCyte Corporation | 83.51M | -3.47% | 15,015 | 1.88M |
| 39 | FONR | FONAR Corporation | 77.24M | -0.89% | 12,290 | 101.57M |
| 40 | NOTV | Inotiv, Inc. | 69.43M | 0.99% | 198,485 | 475.11M |
| 41 | BDSX | Biodesix, Inc. | 68.03M | -10.04% | 922,146 | 71.32M |
| 42 | PRE | Prenetics Global Limited | 63.53M | -2.16% | 11,454 | 30.62M |
| 43 | BNR | Burning Rock Biotech Limited | 25.03M | -12.54% | 152,346 | 70.67M |
| 44 | PRPH | ProPhase Labs, Inc. | 12.34M | -10.92% | 786,592 | 6.77M |
| 45 | PRPO | Precipio, Inc. | 10.30M | -6.40% | 2,593 | 18.53M |
| 46 | MYNZ | Mainz Biomed N.V. | 8.48M | -1.93% | 132,271 | 893.99K |
| 47 | STRR | Star Equity Holdings, Inc. | 7.18M | 1.35% | 7,944 | 53.36M |
| 48 | BIAF | bioAffinity Technologies, Inc. | 6.72M | -16.39% | 310,804 | 9.36M |
| 49 | APDN | Applied DNA Sciences, Inc. | 5.75M | -0.67% | 139,378 | 3.74M |
| 50 | CHEK | Check-Cap Ltd. | 5.03M | 13.14% | 70,166 | - |
| 51 | XWEL | XWELL, Inc. | 4.41M | 5.81% | 13,873 | 33.90M |
| 52 | NDRA | ENDRA Life Sciences Inc. | 3.47M | 0.41% | 38,359 | - |
| 53 | ISPC | iSpecimen Inc. | 3.07M | -1.60% | 345,572 | 9.29M |